Zentiva, k.s., U Kabelovny 130 102 00, Praha 10, Czech Republic; University of Basel, Department of Pharmaceutical Sciences, Klingelbergstrasse 50 4056, Basel, Switzerland; University of Applied Sciences and Arts Northwest. Switzerland, School of Life Sciences, Institute of Pharma Technology, Hofackerstr. 30 CH- 4132, Muttenz, Switzerland.
Zentiva, k.s., U Kabelovny 130 102 00, Praha 10, Czech Republic.
Int J Pharm. 2024 Aug 15;661:124418. doi: 10.1016/j.ijpharm.2024.124418. Epub 2024 Jul 2.
There is increasing pharmaceutical interest in deep eutectic solvents not only as a green alternative to organic solvents in drug manufacturing, but also as liquid formulation for drug delivery. The present work introduces a hydrophobic deep eutectic solvent (HDES) to the field of lipid-based formulations (LBF). Phase behavior of a mixture with 2:1 M ratio of decanoic- to dodecanoic acid was studied experimentally and described by thermodynamic modelling. Venetoclax was selected as a hydrophobic model drug and studied by atomistic molecular dynamics simulations of the mixtures. As a result, valuable molecular insights were gained into the interaction networks between the different components. Moreover, experimentally the HDES showed greatly enhanced drug solubilization compared to conventional glyceride-based vehicles, but aqueous dispersion behavior was limited. Hence surfactants were studied for their ability to improve aqueous dispersion and addition of Tween 80 resulted in lowest droplet sizes and high in vitro drug release. In conclusion, the combination of HDES with surfactant(s) provides a novel LBF with high pharmaceutical potential. However, the components must be finely balanced to keep the integrity of the solubilizing HDES, while enabling sufficient dispersion and drug release.
制药行业对深共熔溶剂的兴趣日益浓厚,不仅将其视为药物制造中有机溶剂的绿色替代品,还将其视为药物传递的液体制剂。本工作将疏水性深共熔溶剂(HDES)引入脂质基制剂(LBF)领域。实验研究了癸酸-十二酸摩尔比为 2:1 的混合物的相行为,并通过热力学模型进行了描述。选择 Venetoclax 作为疏水性模型药物,并对混合物进行了原子分子动力学模拟研究。结果,深入了解了不同成分之间的相互作用网络。此外,实验表明,与传统的甘油酯基载体相比,HDES 大大提高了药物的溶解度,但水分散行为受到限制。因此,研究了表面活性剂改善水分散的能力,添加 Tween 80 可得到最低的液滴尺寸和高体外药物释放。总之,HDES 与表面活性剂(s)的结合提供了一种具有高药物潜力的新型 LBF。然而,必须精细平衡各成分,以保持溶解 HDES 的完整性,同时实现足够的分散和药物释放。